Anesthesia methods, neuroprotection, and surgical field in FESS with controlled hypotension
Official title: FUNCTIONAL ENDOSCOPIC NASAL AND SINUS SURGERY AND ANESTHESIA: Study of Hemodynamic Parameters During General Anesthesia Compared to the Surgical Field, as Well as Assessment of Cerebral Ischemia Intraoperatively by Measurement of S100B Protein and Specific Neuronal Enolase (NSE).
Run by University General Hospital of Patras · NCT07181564 · Data updated 2026-11-12
This trial tests whether four different anesthesia maintenance techniques — propofol-remifentanil, propofol-remifentanil with ketamine and magnesium, sevoflurane-remifentanil, and sevoflurane-remifentanil with ketamine and magnesium — better protect the brain and improve the surgical field in adults having FESS under controlled hypotension.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | University General Hospital of Patras Academic / other |
| Locations | 1 site (Pátrai, Achaia) |
| Status | Recruiting |
| Started | September 11, 2025 |
| Main results expected | February 2, 2026 |
| Study ends | March 20, 2026 |
| Registry record updated | September 18, 2025 |
| Trial ID | NCT07181564 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) scheduled for elective FESS under general anesthesia who can give informed consent and do not have severe hepatic or renal dysfunction, pregnancy, or contraindications to the study drugs are ideal candidates.
✕Probably not a fit
Patients having emergency surgery, with ASA IV–V, severe hepatic or renal failure, pregnancy or lactation, known allergy to study drugs, or inability to consent would not be eligible and thus would not receive benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, single-center randomized trial enrolls adult patients undergoing elective functional endoscopic sinus surgery (FESS) under controlled hypotension and randomizes them to one of four anesthesia maintenance regimens: propofol-remifentanil, propofol-remifentanil plus continuous ketamine and magnesium, sevoflurane-remifentanil, or sevoflurane-remifentanil plus continuous ketamine and magnesium. Primary outcomes are serum biomarkers of neuronal injury (S100B and neuron-specific enolase) measured at baseline, 20 minutes after initiation of controlled hypotension, and at the end of surgery, alongside blinded surgeon ratings of surgical field visibility and intraoperative bleeding. Secondary outcomes include extubation conditions measured by the Aldrete score, postoperative pain by visual analogue scale, and recovery profile. The trial examines whether adjunct ketamine and magnesium provide added neuroprotection during periods of controlled hypotension while maintaining hemodynamic stability and acceptable surgical conditions.
Why it matters
Potential benefit: If successful, adding ketamine and magnesium could lower markers of neuronal injury, reduce bleeding and improve surgical visibility and recovery for patients having FESS under hypotension.
How similar studies have gone: Some prior studies suggest ketamine and magnesium may have neuroprotective or anesthetic-sparing effects in other surgical contexts, but evidence in FESS under controlled hypotension is limited and mixed, making this application relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria : Adult patients (≥18 years old). Scheduled for F.E.S.S (Functional endoscopic sinus surgery ) under general anesthesia. Able to provide informed consent Exclusion Criteria: Emergency surgery. ASA physical status IV-V. Severe hepatic or renal dysfunction. Known allergy or contraindication to study drugs. Pregnant or lactating women. unable to provide informed consent Patients unwilling or unable to provide consent.
Where it's running
-
University General Hospital of Patras
Pátrai, Achaia, Greece Recruiting
Study contacts
- Study coordinator: Sotiria Rizopoulou, M.D.,M.Sc.
- Email: rizsotiria@gmail.com
- Phone: +306949454352
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Combining Ketamine and Magnesium for Pain Relief After Nose Surgery
This study is testing whether combining ketamine and magnesium during nose surgery can help reduce pain and lower the need for opioids afterward.
-
Propofol-Ketamine vs Sevoflurane for anesthesia in kids undergoing heart catheterization
In children needing a heart catheterization, doctors compare using propofol-ketamine versus sevoflurane to see which anesthesia approach is safer and helps kids wake up smoothly.
-
Lower vs higher ketamine doses to reduce the oculocardiac reflex in eye surgery
A single-dose comparison tests whether 0.5 mg/kg IV ketamine works as well as 0.75 mg/kg IV for lowering the oculocardiac reflex in adults having eye surgery.
-
Dexmedetomidine vs magnesium as intraperitoneal add-ons to bupivacaine for laparoscopic gallbladder removal
This study tests whether adding dexmedetomidine or magnesium sulfate to bupivacaine injected inside the abdomen provides better pain relief after laparoscopic cholecystectomy for adults without serious health issues.
-
Biomarker-guided antidepressant choice to see if rTMS or ketamine works best for you
This study tests whether brain and behavior markers can help match people with major depression to either rTMS or ketamine to see which works better for them.
-
Rural Telemedicine-Enabled Care to Prevent Stroke in Older Adults in China
A telemedicine-supported care model led by rural doctors will be tested to see if it can reduce stroke and heart problems in adults 65+ living in rural China.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.